While direct short- and long-term effects of CDK4/6i’s on the cell cycle vanish, an experimental study on ductal BC recently uncovered that genes associated with differentiation, inflammation, IFNγ response, and antigen processing are preserved in tumor and TME after palbociclib treatment [129]. This evidence concerns the gene CDK4 and breast cancer.